Results 181 to 190 of about 178,306 (248)

Optimizing the "right" patient selection for treatment for sickle cell disease. [PDF]

Hematology Am Soc Hematol Educ Program
Colombatti R, Reggiani G.
europepmc   +1 more source

Advances and Gaps in Global Newborn Screening for Sickle Cell Disease. [PDF]

Int J Neonatal Screen
Shook LM, Ware RE.
europepmc   +1 more source

Priapism as an Initial Presentation of Sickle Cell Disease: A Case Report. [PDF]

Cureus
Abebe SG, Cleveland C, Kohavi M, Zafar S, Yanik B.   +4 more
europepmc   +1 more source

Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis. [PDF]

Int J Neonatal Screen
Rahiman EA, Anne RP, Warrier RP.
europepmc   +1 more source

Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date

, 2019
Riley TR, Riley TT
openalex   +1 more source

Role of the primary healthcare providers in sickle cell disease management: a scoping review. [PDF]

J Community Genet
Gazta P, Gautam J, Thakor M, Bhardwaj P, Mohanty SS.   +4 more
europepmc   +1 more source

Biological parenthood rates among men with sickle cell disease. [PDF]

Blood Adv
Young AN, Hayford SR, Chandrasena SS, Conroy S, Karkare TP, Kroner BL, King A, Cronin RM, Badolato L, Nahata L, Creary SE.   +10 more
europepmc   +1 more source

Sickle Cell Disease in 2025: Sustained Progress Amid Challenges

Samuel Wilson
openalex   +1 more source

The role of hydroxyurea in modulating miRNA expression in sickle cell disease: molecular mechanisms and therapeutic implications. [PDF]

Ann Hematol
Mirzaee F, Khamoushi A, Dolati R, Abbasi A.   +3 more
europepmc   +1 more source

End points for sickle cell disease clinical trials: Renal and cardiopulmonary, cure, and low-resource settings [PDF]

, 2019
al., et, Farrell, Ann T., Shenoy, Shalini   +2 more
core   +1 more source